Patents by Inventor Saif Zaman

Saif Zaman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952635
    Abstract: The present disclosure relates to biomarkers and methods for determining or predicting survival of patients with low grade glioma (LGG) or pediatric neuroblastoma. Further disclosed are methods of diagnosing and treating patients with low grade glioma (LGG) or pediatric neuroblastoma.
    Type: Grant
    Filed: March 17, 2022
    Date of Patent: April 9, 2024
    Assignee: University of South Florida
    Inventors: George Blanck, Saif Zaman, Boris Il'ich Chobrutskiy
  • Publication number: 20230399408
    Abstract: This disclosure relates to multi specific antibodies (e.g., bi specific antibodies) or antigen binding fragments thereof. In one aspect, the multispecific antibodies or antigen-binding fragments thereof binds to cMET and/or EGFR, or a combination thereof. An antibody or antigen-binding fragment thereof that binds to cMET (tyrosine-protein kinase Met), comprising: a heavy-chain antibody variable domain (VHH) comprising complementarity determining regions (CDRs) 1, 2, and 3.
    Type: Application
    Filed: November 16, 2021
    Publication date: December 14, 2023
    Inventors: Mohd Saif Zaman, Yue Liu
  • Publication number: 20220205052
    Abstract: The present disclosure relates to biomarkers and methods for determining or predicting survival of patients with low grade glioma (LGG) or pediatric neuroblastoma. Further disclosed are methods of diagnosing and treating patients with low grade glioma (LGG) or pediatric neuroblastoma.
    Type: Application
    Filed: March 17, 2022
    Publication date: June 30, 2022
    Inventors: George Blanck, Saif Zaman, Boris Il'ich Chobrutskiy
  • Patent number: 11279981
    Abstract: The present disclosure relates to biomarkers and methods for determining or predicting survival of patients with low grade glioma (LGG) or pediatric neuroblastoma. Further disclosed are methods of diagnosing and treating patients with low grade glioma (LGG) or pediatric neuroblastoma.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: March 22, 2022
    Assignee: University of South Florida
    Inventors: George Blanck, Saif Zaman, Boris Il'ich Chobrutskiy
  • Publication number: 20200095645
    Abstract: The present disclosure relates to biomarkers and methods for determining or predicting survival of patients with low grade glioma (LGG) or pediatric neuroblastoma. Further disclosed are methods of diagnosing and treating patients with low grade glioma (LGG) or pediatric neuroblastoma.
    Type: Application
    Filed: September 24, 2019
    Publication date: March 26, 2020
    Applicant: University of South Florida
    Inventors: George Blanck, Saif Zaman, Boris Il'ich Chobrutskiy